JP7068277B2 - Eaat3阻害剤としてのイミダゾール化合物 - Google Patents
Eaat3阻害剤としてのイミダゾール化合物 Download PDFInfo
- Publication number
- JP7068277B2 JP7068277B2 JP2019514255A JP2019514255A JP7068277B2 JP 7068277 B2 JP7068277 B2 JP 7068277B2 JP 2019514255 A JP2019514255 A JP 2019514255A JP 2019514255 A JP2019514255 A JP 2019514255A JP 7068277 B2 JP7068277 B2 JP 7068277B2
- Authority
- JP
- Japan
- Prior art keywords
- tert
- butyl
- benzamide
- formula
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16193871 | 2016-10-14 | ||
| EP16193871.7 | 2016-10-14 | ||
| PCT/EP2017/075875 WO2018069362A1 (en) | 2016-10-14 | 2017-10-11 | Imidazole compounds as eaat3 inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019532050A JP2019532050A (ja) | 2019-11-07 |
| JP2019532050A5 JP2019532050A5 (cg-RX-API-DMAC7.html) | 2020-11-19 |
| JP7068277B2 true JP7068277B2 (ja) | 2022-05-16 |
Family
ID=57136749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019514255A Expired - Fee Related JP7068277B2 (ja) | 2016-10-14 | 2017-10-11 | Eaat3阻害剤としてのイミダゾール化合物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US10556870B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3526201B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7068277B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN109563049B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018069362A1 (cg-RX-API-DMAC7.html) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011502148A (ja) | 2007-10-31 | 2011-01-20 | メルク・シャープ・エンド・ドーム・コーポレイション | 疼痛の治療用としてのp2x3受容体アンタゴニスト |
| JP2011506520A (ja) | 2007-12-17 | 2011-03-03 | エフ.ホフマン−ラ ロシュ アーゲー | 新規なイミダゾール置換アリールアミド |
| WO2014193248A1 (en) | 2013-05-31 | 2014-12-04 | The A2 Milk Company Limited | Beta-casein a2 and prevention of inflammation of the bowel |
| JP2016529238A (ja) | 2013-07-18 | 2016-09-23 | ノバルティス アーゲー | 補体因子d阻害剤としてのアミノメチル−ビアリール誘導体およびその使用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5882926A (en) * | 1993-10-20 | 1999-03-16 | Oregon Health Sciences University | Excitatory amino acid transporter gene and uses |
| JP2006151954A (ja) | 2004-10-27 | 2006-06-15 | Taisho Pharmaceut Co Ltd | アスパラギン酸誘導体 |
| US7939556B2 (en) | 2005-10-14 | 2011-05-10 | Neurosearch A/S | Imidazole derivatives and their use for modulating the GABAA receptor complex |
| ES2596706T3 (es) | 2006-06-29 | 2017-01-11 | F. Hoffmann-La Roche Ag | Arilamidas con sustitución de tetrazol |
| KR101186704B1 (ko) | 2007-10-04 | 2012-09-27 | 에프. 호프만-라 로슈 아게 | 테트라졸-치환된 아릴 아마이드 유도체 및 이의 용도 |
| KR101405746B1 (ko) | 2007-12-17 | 2014-06-10 | 에프. 호프만-라 로슈 아게 | 트리아졸 치환된 아릴아미드 유도체 및 p2x3 및/또는 p2x2/3 퓨린성 수용체 길항제로서의 용도 |
| DK2234976T3 (da) | 2007-12-17 | 2013-06-24 | Hoffmann La Roche | Nye pyrazol-substituerede arylamider |
| TW201006801A (en) | 2008-07-18 | 2010-02-16 | Lilly Co Eli | Imidazole carboxamides |
| US20110237578A1 (en) | 2008-09-18 | 2011-09-29 | Zhi-Liang Wei | Amide compounds, compositions and uses thereof |
| CA2741666C (en) | 2008-10-31 | 2017-04-11 | Merck Sharp & Dohme Corp. | P2x3, receptor antagonists for treatment of pain |
| US10577332B2 (en) | 2015-04-23 | 2020-03-03 | Hoffmann-La Roche Inc. | Tetrazole derivatives |
| CN107531642B (zh) | 2015-06-04 | 2021-06-22 | 豪夫迈·罗氏有限公司 | 咪唑衍生物 |
| JP6846363B2 (ja) | 2015-07-14 | 2021-03-24 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 2−フェニル−6−イミダゾリル−ピリジン−4−カルボキサミド誘導体及びそのeaat3阻害剤としての使用 |
| WO2017025523A1 (en) | 2015-08-12 | 2017-02-16 | F. Hoffmann-La Roche Ag | Pyridine and pyrimidine derivatives |
| WO2017060202A1 (en) | 2015-10-06 | 2017-04-13 | F. Hoffmann-La Roche Ag | Triazole derivatives |
| ITUB20154829A1 (it) | 2015-10-27 | 2017-04-27 | Giuseppe Galtieri | Dispositivo ad impulsi dinamici da traffico veicolare e relativo kit. |
| EP3411365B1 (en) | 2016-02-02 | 2019-11-20 | H. Hoffnabb-La Roche Ag | Pyrazol-pyridine derivatives as eaat3 inhibitors |
| CN109071451B (zh) | 2016-05-27 | 2022-07-15 | 豪夫迈·罗氏有限公司 | 作为eaat3抑制剂的吡唑化合物 |
-
2017
- 2017-10-11 WO PCT/EP2017/075875 patent/WO2018069362A1/en not_active Ceased
- 2017-10-11 EP EP17780444.0A patent/EP3526201B1/en active Active
- 2017-10-11 JP JP2019514255A patent/JP7068277B2/ja not_active Expired - Fee Related
- 2017-10-11 CN CN201780045776.7A patent/CN109563049B/zh not_active Expired - Fee Related
-
2019
- 2019-04-12 US US16/382,540 patent/US10556870B2/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011502148A (ja) | 2007-10-31 | 2011-01-20 | メルク・シャープ・エンド・ドーム・コーポレイション | 疼痛の治療用としてのp2x3受容体アンタゴニスト |
| JP2011506520A (ja) | 2007-12-17 | 2011-03-03 | エフ.ホフマン−ラ ロシュ アーゲー | 新規なイミダゾール置換アリールアミド |
| WO2014193248A1 (en) | 2013-05-31 | 2014-12-04 | The A2 Milk Company Limited | Beta-casein a2 and prevention of inflammation of the bowel |
| JP2016529238A (ja) | 2013-07-18 | 2016-09-23 | ノバルティス アーゲー | 補体因子d阻害剤としてのアミノメチル−ビアリール誘導体およびその使用 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2019532050A (ja) | 2019-11-07 |
| US10556870B2 (en) | 2020-02-11 |
| EP3526201A1 (en) | 2019-08-21 |
| WO2018069362A1 (en) | 2018-04-19 |
| CN109563049B (zh) | 2022-11-29 |
| CN109563049A (zh) | 2019-04-02 |
| EP3526201B1 (en) | 2020-11-18 |
| US20190233379A1 (en) | 2019-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7794910B2 (ja) | Eaat2活性化因子およびその使用方法 | |
| JP6518789B2 (ja) | 精神障害の処置において使用するためのテトラゾール誘導体 | |
| CN105793259A (zh) | 氟-萘基衍生物 | |
| JP6877359B2 (ja) | イミダゾール誘導体 | |
| EP3368522B1 (en) | Pyridine or pyrimidine derivatives | |
| JP6846363B2 (ja) | 2−フェニル−6−イミダゾリル−ピリジン−4−カルボキサミド誘導体及びそのeaat3阻害剤としての使用 | |
| JP6905988B2 (ja) | Eaat3阻害剤としてのピラゾール−ピリジン誘導体 | |
| JP6831376B2 (ja) | トリアゾール誘導体 | |
| JP6936257B2 (ja) | Eaat3阻害剤としてのピラゾール化合物 | |
| JP2018531253A6 (ja) | トリアゾール誘導体 | |
| JP2019532050A (ja) | Eaat3阻害剤としてのイミダゾール化合物 | |
| EP1539687A1 (en) | Substituted glycine derivatives for use as medicaments | |
| HK40004826B (en) | Imidazole compounds as eaat3 inhibitors | |
| HK40004826A (en) | Imidazole compounds as eaat3 inhibitors | |
| HK1262810B (en) | Pyrazol compounds as eaat3 inhibitors | |
| HK1262810A1 (en) | Pyrazol compounds as eaat3 inhibitors | |
| HK1081441B (zh) | 对钙通道α-2-δ亚基具有亲合力的脯氨酸衍生物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20201005 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20201005 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20210831 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210907 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20211130 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20211221 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220314 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20220405 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20220428 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7068277 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| LAPS | Cancellation because of no payment of annual fees |